Skip to search formSkip to main contentSkip to account menu

Celiprolol

Known as: Urea, N'-(3-acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethyl-, RS)-N'-{3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N,N-diethylurea, Celiprolol [Chemical/Ingredient] 
A cardioselective beta-1 adrenergic antagonist that has intrinsic symopathomimetic activity. It is used in the management of ANGINA PECTORIS and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
The present study was designed to investigate, in patients with severe heart failure, the dose-dependent acute hemodynamic… 
1997
1997
: A prospective evaluation of the metabolic effects of Celiprolol, a third generation Beta-Blocking agent was done by 10 general… 
1994
1994
beta-Receptor blockers may exert a spectrum of metabolic and humoral effects, which might differ depending on the specific… 
Review
1988
Review
1988
: The results of an extensive pre-clinical and clinical research programme indicate that celiprolol is a safe and effective… 
1988
1988
SUMMARY Celiprolol (400 mg) and atenolol (100 mg) were given once a day to 16 patients with stable angina pectoris in a double… 
1986
1986
In some animal models, celiprolol, a cardioselective beta-adrenoceptor antagonist, has been reported to relax bronchial smooth… 
1986
1986
The absolute configuration of (+)-celiprolol ([alpha]D = +6.3 degrees in CHCl3) was established by a 9-step synthesis via the… 
1986
1986
Studies were conducted to evaluate the effects of celiprolol on alpha-adrenergic stimulation of dog saphenous vein rings… 
Review
1985
Review
1985
The Intrinsic Sympathetic Activity (ISA) of the beta-1-adrenoceptor blocker celiprolol was tested in a series of pharmacological… 
1982
1982
Selective beta 1-blocking drugs without bronchoconstrictor effect are desirable in patients with bronchial asthma and systemic…